Article Information
History
- August 22, 2024.
Article Versions
- Version 1 (June 27, 2024 - 11:01).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chemtai Mungo, MD, MPH1,2,*,
- Katherine Sorgi1,
- Caroline Hoch, BS3,
- Jennifer Tang, MD, MSCR1,
- Lisa Rahangdale, MD, MPH1,2 and
- Jackton Omoto, MBChB4
- 1Department of Obstetrics and Gynecology, University of North Carolina Chapel Hill, 321 S Columbia St, Chapel Hill, North Carolina, 27599, USA
- 2Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, 450 West Dr, Chapel Hill, North Carolina, 27599, USA
- 3UNC Gillings School of Global Public Health, 170 Rosenau Hall, Campus Box 7400, 135 Dauer Drive, Chapel Hill, NC 27599
- 4Department of Obstetrics and Gynecology, Maseno University School of Medicine, P.O. Box 3408, Kisumu, Kenya
- ↵*Corresponding Author: Chemtai Mungo, MD, MPH, chemtai_mungo{at}med.unc.edu
Posted August 22, 2024.
Intravaginal artesunate pessaries for treatment of cervical intraepithelial neoplasia 2/3 among HIV-positive and HIV-negative women in Kenya: Study protocol for a pilot trial
